The recent and successful human implantation of a 3D-printed vertebra at Peking University in China captured the public’s imagination. I read the news (and its quick spread) as evidence that medical devices are, dare I say, cool again. I’ve never seen a flood of interest as we have enjoyed recently. This is a great thing; I…
Details
Check out some of the hottest developments in medical technology below! Focused Ultrasound Imagine if brain tumor removal required only mild sedation and no hospital stay. That’s the promise of focused ultrasound technology, which combines real-time magnetic resonance imaging and an ultrasound transducer to noninvasively ablate tissue. Approved around the world for indications such as…
Details
Three-way partnership out of Peterborough, Ontario, Canada, sets the stage for a radical change in injection drug delivery for patients worldwide. Peterborough, Ontario, Canada – A partnership of three Peterborough Ontario-based companies is set to start production of its final generation of a unique patented micro-needle drug delivery system, using state-of-the-art equipment unavailable anywhere else…
Details
It is that time of the year again! Every December, SERI shows its holiday spirit through decorations and celebrations. The annual SERI holiday decorating event took place last week–a time for friends and family of SERI to join hands and put on a flashy show in the amphitheater and hallways. If you get a chance,…
Details
Implantable Gel May Revolutionize the Treatment of Patients Who Lose the Ability to Pump Blood Efficiently to the Body LAGUNA HILLS, Calif., Oct. 1, 2014 /PRNewswire/ — LoneStar Heart, Inc. today announced that it received the CE Mark (Conformite Europeene) for its Algisyl-LVR® hydrogel implant, the company’s lead product for the treatment of advanced heart…
Details
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, presented its latest findings on the investigational use of the Zenascope® in cervical cancer screening at the U.S. Investigators’ Symposium on Global Non-Communicable Disease Research on September 8th and 9th. The poster – titled “Towards a viable solution for a see and treat paradigm for cervical pre-cancer…
Details
3rd FDA panel vote barely favors Boston Scientific’s Watchman anti-stroke device Medtronic launches Verify incontinence device in the U.S FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard’s Lutonix DEB An FDA advisory panel offered a mixed view of Boston Scientific’s Watchman heart device earlier this month, concluding it is probably safe but not…
Details
C.R. Bard ($BCR) won a unanimous vote from an FDA advisory panel for its drug-eluting balloon catheter, setting the stage for the device’s full regulatory approval. The FDA’s Circulatory System Devices Advisory Panel recommended that the company’s Lutonix drug-coated balloon PTA catheter (DCB) be approved in the U.S. to treat peripheral artery disease (PAD) by…
Details
Startup InSilixa has developed a chip it claims can run highly accurate DNA tests in an hour for less than $20 per test on a handheld reader that will cost about $250. The Hydra-1K could drastically undercut the expense and time required of current methods of detecting diseases, bringing molecular diagnostics to the point of…
Details
Rates of melanoma have been increasing significantly over the past 30 years. The skin cancer now accounts for around 5% of all new cancers in the US, and there are expected to be 76,100 new cases and 9,710 deaths from the disease this year. Now, the Food and Drug Administration (FDA) have granted fast-track approval…
Details